Antigen targeting and anti-tumor activity of a novel anti-CD146 212Pb internalizing alpha-radioimmunoconjugate against malignant peritoneal mesothelioma
Abstract Malignant mesothelioma, a highly aggressive cancer that primarily affects the serosal membranes, has limited therapeutic options, particularly for cavitary tumors, such as peritoneal and pleural malignant mesothelioma. Intracavitary administration of a radioimmunoconjugate to locally target...
Saved in:
| Main Authors: | Kim Lindland, Marion Masitsa Malenge, Ruth Gong Li, Roxanne Wouters, Tina Bjørnlund Bønsdorff, Asta Juzeniene, Srdan M. Dragovic |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-10-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-024-76778-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Half-life measurements of 212Po with thorium-loaded liquid scintillator
by: P. Belli, et al.
Published: (2018-09-01) -
212Pb in targeted radionuclide therapy: a review
by: Jarred Michael Scaffidi-Muta, et al.
Published: (2025-07-01) -
Preliminary biological evaluation of 123I-labelled anti-CD30-LDM in CD30-positive lymphomas murine models
by: Jianhua Gong, et al.
Published: (2020-01-01) -
Lead-212 Radiopharmaceuticals for Receptor-Targeted Radionuclide Therapy
by: Solmaz Mojarad-Jabali, et al.
Published: (2025-01-01) -
Incidence and Outcomes of Brain Metastasis in Pleural Mesothelioma in the Era of Immunotherapy
by: Margaret Stalker, MD, et al.
Published: (2025-05-01)